< Return to trials

Osteoporosis

Overview

Lillestol Research has performed multiple trials involving the osteoporosis/osteopenia indication/diagnosis. The trials have varied in phase, enrollment criteria, and trial duration. Osteoporosis is one of our most experienced trial indications to recruit to, and it was Dr. Lillestol’s first indication experience in clinical trial work. Dr. Lillestol’s trial work in this indication is impressive, and it has led to many strides in the industry’s development of available treatments for osteoporosis. The multitude of trials that we have performed in this indication has developed a robust research patient database of over 1,000 individuals with an osteoporosis diagnosis that would be interested in clinical trial participation.

Spotlight Trial(s)

  1. This was a long-term investigational product trial to assess the incidence of vertebral fracture and invasive breast cancer in postmenopausal women with low bone density. Lillestol Research was a top enroller to the trial and was able to successfully meet and far exceed the sponsor’s enrollment expectation randomizing 37 patients to the trial.
  2. This was an open-label patient satisfaction trial of an investigational product in comparison with an after-market product in postmenopausal women with low bone mineral density. Lillestol Research was able to successfully meet and exceed the sponsor’s enrollment expectation randomizing 15 patients to the trial in a 7-month enrollment period.
  3. This was an open-label trial of an investigational product in comparison with an after-market product in postmenopausal women sub-optimally treated with bisphosphonates. Lillestol Research was able to successfully meet and exceed the sponsor’s enrollment expectation randomizing 17 patients to the trial in an 11-month enrollment period.